Literature DB >> 24614674

Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Heiani Touaitahuata1, Anne Blangy1, Virginie Vives1.   

Abstract

Bone is a dynamic tissue constantly renewed through a regulated balance between bone formation and resorption. Excessive bone degradation by osteoclasts leads to pathological decreased bone density characteristic of osteolytic diseases such as post-menopausal osteoporosis or bone metastasis. Osteoclasts are multinucleated cells derived from hematopoietic stem cells via a complex differentiation process. Their unique ability to resorb bone is dependent on the formation of the actin-rich sealing zone. Within this adhesion structure, the plasma membrane differentiates into the ruffled border where protons and proteases are secreted to demineralize and degrade bone, respectively. On the bone surface, mature osteoclasts alternate between stationary resorptive and migratory phases. These are associated with profound actin cytoskeleton reorganization, until osteoclasts die of apoptosis. In this review, we highlight the role of Rho GTPases in all the steps of osteoclasts differentiation, function, and death and conclude on their interest as targets for treatment of osteolytic pathologies.

Entities:  

Keywords:  Cdc42; RANK ligand; Rac; Rho GTPase; RhoU; actin; bone and bones; guanine nucleotide exchange factor; osteoclast; podosome

Mesh:

Substances:

Year:  2014        PMID: 24614674      PMCID: PMC4114643          DOI: 10.4161/sgtp.28119

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  112 in total

1.  Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.

Authors:  Olivier Destaing; Frédéric Saltel; Jean-Christophe Géminard; Pierre Jurdic; Frédéric Bard
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

2.  Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

Authors:  F P Coxon; M H Helfrich; R Van't Hof; S Sebti; S H Ralston; A Hamilton; M J Rogers
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 3.  Intracellular membrane trafficking in bone resorbing osteoclasts.

Authors:  Mika Mulari; Jukka Vääräniemi; H Kalervo Väänänen
Journal:  Microsc Res Tech       Date:  2003-08-15       Impact factor: 2.769

4.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

Review 5.  Elaborating polarity: PAR proteins and the cytoskeleton.

Authors:  Jeremy Nance; Jennifer A Zallen
Journal:  Development       Date:  2011-03       Impact factor: 6.868

6.  Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.

Authors:  Kim C Mansky; Uma Sankar; Jiahuai Han; Michael C Ostrowski
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

7.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

8.  Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity.

Authors:  Takashi Itokowa; Mei-ling Zhu; Nancy Troiano; Jessica Bian; Tustomu Kawano; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2010-11-26       Impact factor: 4.333

9.  Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.

Authors:  S P Luckman; F P Coxon; F H Ebetino; R G Russell; M J Rogers
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

10.  The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts.

Authors:  D Zhang; N Udagawa; I Nakamura; H Murakami; S Saito; K Yamasaki; Y Shibasaki; N Morii; S Narumiya; N Takahashi
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

View more
  21 in total

1.  Rho GTPases at the crossroad of signaling networks in mammals.

Authors:  Jean Claude Hervé; Nicolas Bourmeyster
Journal:  Small GTPases       Date:  2015-06-25

2.  Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.

Authors:  Nikolaus Binder; Christine Miller; Masaki Yoshida; Kazuki Inoue; Shinichi Nakano; Xiaoyu Hu; Lionel B Ivashkiv; Georg Schett; Alessandra Pernis; Steven R Goldring; F Patrick Ross; Baohong Zhao
Journal:  J Immunol       Date:  2017-03-17       Impact factor: 5.422

Review 3.  Tools of the trade: podosomes as multipurpose organelles of monocytic cells.

Authors:  Stefan Linder; Christiane Wiesner
Journal:  Cell Mol Life Sci       Date:  2014-10-10       Impact factor: 9.261

4.  A multiethnic whole genome sequencing study to identify novel loci for bone mineral density.

Authors:  Jonathan Greenbaum; Kuan-Jui Su; Xiao Zhang; Yong Liu; Anqi Liu; Lan-Juan Zhao; Zhe Luo; Qing Tian; Hui Shen; Hong-Wen Deng
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 5.121

5.  Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.

Authors:  Eun-Jung Lee; Jung-Lye Kim; Ju-Hyun Gong; Sin-Hye Park; Young-Hee Kang
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

6.  Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.

Authors:  Christian Gross; Manuel Weber; Kay Creutzburg; Patrick Möbius; Raimund Preidl; Kerstin Amann; Falk Wehrhan
Journal:  J Transl Med       Date:  2017-06-06       Impact factor: 5.531

7.  Screening for Key Pathways Associated with the Development of Osteoporosis by Bioinformatics Analysis.

Authors:  Yanqing Liu; Yueqiu Wang; Yanxia Zhang; Zhiyong Liu; Hongfei Xiang; Xianbo Peng; Bohua Chen; Guyou Jia
Journal:  Biomed Res Int       Date:  2017-03-30       Impact factor: 3.411

8.  MicroRNAs are Critical Regulators of Osteoclast Differentiation.

Authors:  Henry C Hrdlicka; Sun-Kyeong Lee; Anne M Delany
Journal:  Curr Mol Biol Rep       Date:  2019-01-16

9.  An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility.

Authors:  Riikka E Mäkitie; Petra Henning; Yaming Jiu; Anders Kämpe; Konstantin Kogan; Alice Costantini; Ville-Valtteri Välimäki; Carolina Medina-Gomez; Minna Pekkinen; Isidro B Salusky; Camilla Schalin-Jäntti; Maria K Haanpää; Fernando Rivadeneira; John H Duncan Bassett; Graham R Williams; Ulf H Lerner; Renata C Pereira; Pekka Lappalainen; Outi Mäkitie
Journal:  JBMR Plus       Date:  2021-06-07

10.  JAGGED1 stimulates cranial neural crest cell osteoblast commitment pathways and bone regeneration independent of canonical NOTCH signaling.

Authors:  Archana Kamalakar; Jay M McKinney; Daniel Salinas Duron; Angelica M Amanso; Samir A Ballestas; Hicham Drissi; Nick J Willett; Pallavi Bhattaram; Andrés J García; Levi B Wood; Steven L Goudy
Journal:  Bone       Date:  2020-09-25       Impact factor: 4.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.